Effects of the combination of nicotinic acid and propranolol in very low doses on blood lipids in man.
D001796:Blood Protein Disorders / Q000188:drug therapy*; D001797:Blood Protein Electrophoresis; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D009539:Nicotinic Acids / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D011433:Propranolol